News Medical10m
Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients
Study reveals 0.4%-2.7% incidence of COVID-19-associated pulmonary aspergillosis in severe patients, highlighting significant ...
Managed Healthcare Executive15h
Cancer Drugs Spark Surprising Improvement in PAH Symptoms
New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.
Too Old to Operate3d
Identifying Patients at Risk for Early Mortality After Lung Transplant in IPAH
ECMO or ventilator use was the most significant predictor of mortality in patients undergoing lung transplant for idiopathic ...
The Lancet5d
Serotonin pathway blockade in pulmonary arterial hypertension
In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...